FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RELATLIMAB
异名/同义词BMS-986016
BMS-986213 COMPONENT RELATLIMAB
IMMUNOGLOBULIN G4, ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3 PROTEIN) (HUMAN HEAVY CHAIN), DISULFIDE WITH HUMAN LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE 3 PROTEIN (LAG-3, PROTEIN FDC, CD223 ANTIGEN))
RELATLIMAB
RELATLIMAB [USAN]
RELATLIMAB [WHO-DD]
RELATLIMAB [INN]
OPDUALAG COMPONENT RELATLIMAB-RMBW
RELATLIMAB-RMBW
RELATLIMAB RMBW [WHO-DD]
CAS登记号1673516-98-7
物质唯一标识(Unique Ingredient Identifier)AF75XOF6W3
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System